303 related articles for article (PubMed ID: 33760392)
1. Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort.
Young A; Moles VM; Jaafar S; Visovatti S; Huang S; Vummidi D; Nagaraja V; McLaughlin V; Khanna D
Arthritis Rheumatol; 2021 Sep; 73(9):1731-1737. PubMed ID: 33760392
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.
Hao Y; Thakkar V; Stevens W; Morrisroe K; Prior D; Rabusa C; Youssef P; Gabbay E; Roddy J; Walker J; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
Arthritis Res Ther; 2015 Jan; 17(1):7. PubMed ID: 25596924
[TBL] [Abstract][Full Text] [Related]
3. Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
Distler O; Bonderman D; Coghlan JG; Denton CP; Grünig E; Khanna D; McLaughlin VV; Müller-Ladner U; Pope JE; Vonk MC; Di Scala L; Lemarie JC; Perchenet L; Hachulla É
Arthritis Rheumatol; 2024 May; 76(5):777-782. PubMed ID: 38146100
[TBL] [Abstract][Full Text] [Related]
4. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
Thakkar V; Stevens W; Prior D; Youssef P; Liew D; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
Arthritis Res Ther; 2013; 15(6):R193. PubMed ID: 24246100
[TBL] [Abstract][Full Text] [Related]
5. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
[TBL] [Abstract][Full Text] [Related]
6. High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center.
Guillén-Del Castillo A; Callejas-Moraga EL; García G; Rodríguez-Palomares JF; Román A; Berastegui C; López-Meseguer M; Domingo E; Fonollosa-Plá V; Simeón-Aznar CP
Arthritis Res Ther; 2017 Jun; 19(1):135. PubMed ID: 28615037
[TBL] [Abstract][Full Text] [Related]
7. Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort.
Vandecasteele E; Drieghe B; Melsens K; Thevissen K; De Pauw M; Deschepper E; Decuman S; Bonroy C; Piette Y; De Keyser F; Brusselle G; Smith V
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28495691
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
[TBL] [Abstract][Full Text] [Related]
9. Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions.
Erdogan M; Kilickiran Avci B; Ebren C; Ersoy Y; Ongen Z; Ongen G; Hamuryudan V; Hatemi G
Clin Exp Rheumatol; 2024 Mar; ():. PubMed ID: 38489342
[TBL] [Abstract][Full Text] [Related]
10. Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.
Ninagawa K; Kato M; Nakamura H; Abe N; Kono M; Fujieda Y; Oku K; Yasuda S; Ohira H; Tsujino I; Atsumi T
Rheumatol Int; 2019 Nov; 39(11):1883-1887. PubMed ID: 31280357
[TBL] [Abstract][Full Text] [Related]
11. Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort.
Hoffmann-Vold AM; Fretheim H; Midtvedt Ø; Kilian K; Angelshaug M; Chaudhary A; Gunnarsson R; Brunborg C; Garen T; Andreassen AK; Gude E; Molberg Ø
Rheumatology (Oxford); 2018 Mar; 57(3):480-487. PubMed ID: 29237073
[TBL] [Abstract][Full Text] [Related]
12. [Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Comparison of DETECT algorithm to decisions of a multidisciplinary team, in a competence centre].
Coirier V; Lescoat A; Fournet M; Cazalets C; Coiffier G; Jouneau S; Chabanne C; Jégo P
Rev Med Interne; 2017 Aug; 38(8):502-507. PubMed ID: 28545856
[TBL] [Abstract][Full Text] [Related]
13. How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
Sarı A; Şener YZ; Armağan B; Kılıç L; Kaya EB; Hekimsoy V; Karadağ Ö; Apras Bilgen Ş; Kiraz S; Ertenli I; Tokgozoğlu L; Akdoğan A
Anatol J Cardiol; 2021 Jan; 25(1):30-35. PubMed ID: 33382047
[TBL] [Abstract][Full Text] [Related]
14. DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients.
Colalillo A; Hachulla E; Pellicano C; Smith V; Bergmann C; Riemekasten G; Zanatta E; Henes J; Launay D; Marcoccia A; Gheorghiu AM; Truchetet ME; Iannone F; Simeón Aznar CP; Oliveira S; Vonk M; Del Galdo F; Rosato E;
Chest; 2024 Jun; ():. PubMed ID: 38849072
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
[TBL] [Abstract][Full Text] [Related]
16. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
Colalillo A; Grimaldi MC; Vaiarello V; Pellicano C; Leodori G; Gigante A; Romaniello A; Rosato E
Rheumatology (Oxford); 2022 May; 61(6):2450-2456. PubMed ID: 34605890
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.
Hinchcliff M; Fischer A; Schiopu E; Steen VD;
J Rheumatol; 2011 Oct; 38(10):2172-9. PubMed ID: 21844142
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
Proudman SM; Stevens WM; Sahhar J; Celermajer D
Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
[TBL] [Abstract][Full Text] [Related]
19. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.
Schreiber BE; Valerio CJ; Keir GJ; Handler C; Wells AU; Denton CP; Coghlan JG
Arthritis Rheum; 2011 Nov; 63(11):3531-9. PubMed ID: 21769839
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.
Santaniello A; Casella R; Vicenzi M; Rota I; Montanelli G; De Santis M; Bellocchi C; Lombardi F; Beretta L
Rheumatology (Oxford); 2020 Jul; 59(7):1581-1586. PubMed ID: 31637433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
